Scare over oral contraceptives. Risk is highest during first months of use.
作者信息
Reijnen H B, Atsma W J
出版信息
BMJ. 1995 Dec 16;311(7020):1639. doi: 10.1136/bmj.311.7020.1639a.
Abstract
摘要
相似文献
1
Scare over oral contraceptives. Risk is highest during first months of use.口服避孕药引发恐慌。使用的最初几个月风险最高。
BMJ. 1995 Dec 16;311(7020):1639. doi: 10.1136/bmj.311.7020.1639a.
2
Scare over oral contraceptives. If a woman has not had a thrombotic event in years of use she is unlikely to have one now.对口服避孕药的恐慌。如果一名女性在多年使用口服避孕药期间未发生血栓形成事件，那么她现在也不太可能发生。
BMJ. 1995 Dec 16;311(7020):1638-9. doi: 10.1136/bmj.311.7020.1638c.
3
Scare over oral contraceptives. Was Committee on Safety of Medicines' advice arrived at lawfully?口服避孕药恐慌。药品安全委员会的建议是合法得出的吗？
BMJ. 1995 Dec 16;311(7020):1640. doi: 10.1136/bmj.311.7020.1640.
4
Scare over oral contraceptives. Committee's action will undermine further research and development.对口服避孕药的恐慌。委员会的行动将破坏进一步的研发。
BMJ. 1995 Dec 16;311(7020):1639-40. doi: 10.1136/bmj.311.7020.1639c.
5
Scare over oral contraceptives ... and south Wales.对口服避孕药的恐慌……以及南威尔士。
BMJ. 1995 Dec 16;311(7020):1637-8. doi: 10.1136/bmj.311.7020.1637b.
6
Scare over oral contraceptives. Doctors should take warning seriously.对口服避孕药的恐慌。医生应认真对待这一警告。
BMJ. 1995 Dec 16;311(7020):1638. doi: 10.1136/bmj.311.7020.1638b.
7
Scare over oral contraceptives. Committee's action has compromised continuing studies.口服避孕药恐慌。委员会的行动危及了后续研究。
BMJ. 1995 Dec 16;311(7020):1639. doi: 10.1136/bmj.311.7020.1639.
8
Scare over oral contraceptives. Effect on behaviour of women attending a family planning clinic.对口服避孕药的恐慌。对前往计划生育诊所的女性行为的影响。
BMJ. 1995 Dec 16;311(7020):1637. doi: 10.1136/bmj.311.7020.1637.
9
Scare over oral contraceptives. Effect on women in a general practice in Devon..对口服避孕药的恐慌。对德文郡一家普通诊所女性的影响。
BMJ. 1995 Dec 16;311(7020):1637. doi: 10.1136/bmj.311.7020.1637a.
10
引用本文的文献
1
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.口服避孕药使用者的闭塞性血管疾病。流行病学、病理学及发病机制。
Drugs. 2000 Oct;60(4):721-869. doi: 10.2165/00003495-200060040-00003.
2
Third generation oral contraceptives. Postmarketing surveillance does not catch all adverse events.第三代口服避孕药。上市后监测无法发现所有不良事件。
BMJ. 1996 Mar 2;312(7030):577. doi: 10.1136/bmj.312.7030.577.
本文引用的文献
1
Third generation oral contraceptive pills.第三代口服避孕药
BMJ. 1995 Oct 28;311(7013):1112. doi: 10.1136/bmj.311.7013.1112.
2
Advising women on which pill to take.就服用哪种避孕药向女性提供建议。
BMJ. 1995 Oct 28;311(7013):1111-2. doi: 10.1136/bmj.311.7013.1111.
Zotero 插件